Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026

Core Insights - Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing first- or best-in-class therapies for autoimmune diseases and cancer [3] Group 1: Company Overview - Cullinan Therapeutics is advancing high-impact therapies leveraging expertise in T cell engagers, which are currently established in oncology and expanding into autoimmune diseases [3] - The company has a clinical-stage pipeline built on a rigorous scientific approach and innovation aimed at delivering new standards of care for patients [3] Group 2: Upcoming Events - The CEO Nadim Ahmed and CMO Jeffrey Jones will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026, at 11:00 a.m. ET [1] - A webcast of the fireside chat will be available on the company's investor relations website [2]